⁶⁴Cu-SAR-Bombesin PET-CT Imaging in the Staging of Estrogen/Progesterone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients: Safety, Dosimetry and Feasibility in a Phase I Trial

• Main Authors: Keith Wong (Author), Gemma Sheehan-Dare (Author), Andrew Nguyen (Author), Bao Ho (Author), Victor Liu (Author), Jonathan Lee (Author), Lauren Brown (Author), Rachel Dear (Author), Lyn Chan (Author), Shikha Sharma (Author), Alessandra Malaroda (Author), Isabelle Smith (Author), Elgene Lim (Author), Louise Emmett (Author)
• Format: Book
• Published: MDPI AG, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Breast cancers are most frequently oestrogen receptor (ER) and progesterone receptor (PR) positive and [¹⁸F]Fluorodeoxyglucose PET-CT (FDG) has lower sensitivity for these subtypes. The gastrin-releasing peptide receptor (GRPR) is overexpressed in ER+/PR+ breast cancers. This...